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BCL-2-associated athanogene-1 (BAG-1) is expressed by osteoblast-lineage cells; early 
embryonic lethality in Bag-1 null mice, however, has limited the investigation of BAG-1 
function in osteoblast development. In the present study, bone morphogenetic protein-
2/BMP-2-directed osteogenic differentiation of bone marrow stromal cells (BMSCs) of Bag-
1+/- (heterozygous) female mice was decreased significantly. Genes crucial for osteogenic 
differentiation, bone matrix formation and mineralisation were expressed at significantly 
lower levels in cultures of Bag-1+/- BMSCs supplemented with BMP-2, while genes with roles 
in inhibition of BMP-2-directed osteoblastogenesis were significantly upregulated. 17-β-
estradiol (E2) enhanced responsiveness of BMSCs of wild-type and Bag-1+/- mice to BMP-2, 
and promoted robust BMP-2-stimulated osteogenic differentiation of BMSCs. BAG-1 can 
modulate cellular responses to E2 by regulating the establishment of functional estrogen 
receptors (ERs), crucially, via its interaction with heat shock proteins (HSC70/HSP70). 
Inhibition of BAG-1 binding to HSC70 by the small-molecule chemical inhibitor, Thioflavin-S, 
and a short peptide derived from the C-terminal BAG domain, which mediates binding with 
the ATPase domain of HSC70, resulted in significant downregulation of E2/ER-facilitated 
BMP-2-directed osteogenic differentiation of BMSCs. These studies demonstrate for the first 
time the significance of BAG-1-mediated protein-protein interactions, specifically, BAG-1-
regulated activation of ER by HSC70, in modulation of E2-facilitated BMP-2-directed 












Endochondral ossification, the process responsible for formation of majority of the bones that 
make up the skeleton, involves deposition of bone matrix by osteoblasts on intermediary 
cartilaginous primordia, which serve as scaffolds on which bones are subsequently built. 
Postnatally, endochondral ossification contributes to the longitudinal growth of bones and 
healing of bone fractures. Disruption of endochondral bone development results in a 
heterogeneous group of genetic diseases known as skeletal dysplasias that are 
characterised predominantly by short-limb dwarfism and, in certain chondrodysplasias, 
prenatal death1. Furthermore, dysregulation of early skeletal development is directly linked to 
diseases of the adult skeleton such as osteoporosis2,3. Thus, improved appreciation of 
skeletal development will enhance our understanding of musculoskeletal diseases and 
inform the development of novel strategies for replacement/regeneration of skeletal tissues. 
The role of molecular chaperones and their co-chaperones in health and disease has 
attracted significant attention in recent years. Bcl-2-associated athanogene-1 (BAG-1), the 
founding member of the BAG-family of co-chaperones, is a multifunctional protein, capable 
of regulating cell proliferation, motility, differentiation and apoptosis4,5. Murine cells express 
two BAG-1 isoforms, BAG-1L (50 kDa) and BAG-1S (32 kDa), which are generated using 
alternate translation initiation sites in a single Bag-1 mRNA transcript6. During murine 
development, expression of Bag-1 mRNA is detected in several organs, with highest 
expression observed in cartilaginous tissues of the developing mouse embryo7. In long 
bones of postnatal mice, expression of BAG-1 is detected in articular and growth plate 
chondrocytes, in addition to osteoblast-lineage cells, namely bone marrow stromal cells 
(BMSCs), osteoblasts and osteocytes8,9. Remarkably, expression of BAG-1 is upregulated in 
human osteoarthritic cartilage compared to normal articular cartilage, most likely in response 
to the disruption of chondrocyte homeostasis in osteoarthritis10.  
BAG-1 has been demonstrated to play important roles in the protection of mammalian 
chondrocytes against apoptosis induced by endoplasmic reticulum stress and heat shock, 
and in the regulation of expression of chondrogenic markers9,11. In contrast, to date, no 
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studies have investigated the role of Bag-1 in osteoblast development. Gene knockout 
mouse models have proved pivotal in the analyses of bone development. Significant 
apoptosis in the embryonic liver and brain, along with defective haematopoiesis and 
neuronal cell differentiation have been identified as the major causes of death in Bag-1 null 
mice between E (embryonic day) 12.5 and E13.5 of gestation12. Early embryonic lethality in 
Bag-1 null mice has limited the investigation of the role of BAG-1 in bone development. This 
is primarily because vascular invasion of the calcified hypertrophic cartilage, resulting in the 
recruitment of osteoclasts and osteoblasts for the gradual replacement of the cartilaginous 
matrix with bone, occurs between E14.5 and E15.513. Mice heterozygous for the Bag-1 gene 
(i.e. containing one functional Bag-1 allele) are not embryonic lethal and survive into 
adulthood14, thereby allowing investigation of the effect of Bag-1 haploinsufficiency on 
osteoblast differentiation and bone development.  
BAG-1 interacts with a diverse array of molecular targets, namely the 70-kDa heat shock 
chaperone proteins (HSC70/HSP70), RAF-1 kinase, components of the 
ubiquitylation/proteasome machinery and nuclear hormone receptors (NHRs), to regulate 
gene transcription and molecular signalling crucial for cell proliferation, differentiation and 
apoptosis15. Binding of BAG-1 to HSC70/HSP70 has now been acknowledged to be vital for 
most functions of BAG-1, including the effects of BAG-1 on NHRs16,17. The carboxy terminus 
BAG domain is composed of three alpha helices, which facilitate binding between BAG-1 
and the amino terminal ATPase domain of HSC70/HSP7018. Helices 2 and 3 are involved in 
electrostatic interactions with the ATPase domain of HSC70/HSP70; helix 1 is not directly 
involved in the binding process and contributes to the intramolecular interactions that 
stabilise the overall structure of the BAG domain19. A very small region comprising of 8 
amino acid residues in helix 2 of the BAG domain has been shown to be vital for binding of 
BAG-1 to HSC7020.  
NHRs have been recognised as key regulators of cellular function and BAG-1 has been 
shown to regulate the functions of diverse NHRs, namely the glucocorticoid receptor, 
androgen receptor, estrogen receptors (ERs), retinoic acid receptor and vitamin D3 
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receptor21. NHRs (in their non-native states) interact with the central substrate/peptide-
binding domain of the heat shock chaperone proteins and undergo a series of steps in the 
(re)folding/activation process to achieve correct conformations that facilitate binding of the 
NHRs to respective hormones22,23. The ATPase domain of HSC70/HSP70 regulates 
substrate binding through cycles of ATP binding and hydrolysis; substrates interact 
transiently with the ATP-bound form of HSC70/HSP70, while hydrolysis of ATP enables the 
substrates to bind the ADP-bound form of HSC70/HSP70 with high affinity24. Release of 
ADP and subsequent binding of ATP, referred to as nucleotide exchange, permits the 
release of the refolded substrates24.  
BAG-1 interacts with the ATPase domain of HSC70/HSP70 and functions as a nucleotide 
exchange factor in the activation cycle25. Hence, by stimulating nucleotide exchange, BAG-1 
regulates the dynamics of complex assembly crucial for the establishment and release of the 
functional NHRs prior to hormone binding. Thus, BAG-1, through its interaction with 
HSC70/HSP70, regulates the activation of NHRs, including ERs, and can play an important 
role in the modulation of cellular responses to steroid hormones, such as estrogen/17-β-
estradiol (E2). Moreover, after hormone binding, BAG-1 is able to influence receptor-
mediated transcription of the nuclear hormone-responsive genes e.g. BAG-1 has been 
shown to interact with and stimulate the activity of both ERα and ERβ, and enhance E2-
dependent transcription in breast cancer cells26.  
Estrogen exerts a protective effect on bone and has been demonstrated to enhance the 
osteogenic differentiation of osteoprogenitor cells stimulated by bone morphogenetic 
proteins-2/4 (BMP-2/4)27,28. However, the significance of BAG-1-regulated activation of ER 
by HSC70 in the modulation of E2-facilitated BMP-directed osteoblast differentiation has not 
been elucidated to date. Since BAG-1 interacts with most of the molecular targets in cells via 
HSC70/HSP70, disruption of binding of BAG-1 to the heat shock proteins leads to loss of 
BAG-1-mediated protein-protein interactions. Screening of compound collections (obtained 
from the National Cancer Institute Developmental Therapeutics Programme, Rockville, MD) 
for identification of small molecule chemical inhibitors of the interaction between BAG-1 and 
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heat shock proteins resulted in the identification of NSC71948, which was found to be 
structurally similar to Thioflavin-S29. Furthermore, short peptides derived from the C-terminal 
BAG domain, which mediates binding with the ATPase domain of HSC70/HSP70, have been 
shown to inhibit the interaction between BAG-1 and the heat shock proteins20. Inhibition of 
BAG-1-mediated protein-protein interactions through disruption of BAG-1 binding to 
HSC70/HSP70 by Thioflavin-S and the C-terminal BAG domain-derived short peptides 
therefore offers an effective strategy to elucidate the role of BAG-1 in E2/ER-facilitated BMP-
directed osteoblast differentiation. 
The present study aims to examine the effect of Bag-1 haploinsufficiency on osteoblast 
development by analysing the differences in BMP-2-directed osteogenic differentiation of 
BMSCs of Bag-1 heterozygous and wild-type mice. Furthermore, the study seeks to 
investigate the effect of inhibition of the interaction between BAG-1 and HSC70 on E2/ER-
facilitated BMP-2-directed osteogenic differentiation of BMSCs.  
 
Results 
Characterisation of the effects of Bag-1 haploinsufficiency on proliferation, 
osteogenic differentiation and apoptosis of BMSCs  
Genotyping was performed for the identification of wild-type (+/+), Bag-1 heterozygous (+/-) 
and Bag-1 null (-/-) mice (Supplementary Fig. 1A). The results of genotyping were confirmed 
by immunoblotting and quantitation of the expression of BAG-1 isoforms in wild-type, 
heterozygous and null littermates (Supplementary Fig. 1B, C). BMSC cultures of 14-week-
old wild-type and Bag-1 heterozygous mice were utilised for analyses of cell proliferation, 
osteogenic differentiation and apoptosis. Day-28 cultures in basal medium were harvested 
for the preparation of cell lysates for immunoblotting. Immunoblots probed with the anti-BAG-
1 antibody exhibited bands specific for BAG-1L (50 kDa) and BAG-1S (32 kDa) proteins (Fig. 
1A and Supplementary Fig. 2A for female and male mice, respectively). Densitometric 
quantification of the bands was performed to measure the expression levels of the BAG-1L 
and BAG-1S proteins. Lower levels of BAG-1L and BAG-1S proteins were observed in 
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BMSC cultures of Bag-1 heterozygous mice compared to wild-type mice (Fig. 1A and 
Supplementary Fig. 2A for female and male mice, respectively). The immunoblots also 
demonstrated intense bands for BAG-1S compared to BAG-1L in BMSC cultures of both 
wild-type and Bag-1 heterozygous mice, indicating higher expression of BAG-1S in 
comparison to BAG-1L in murine BMSCs. 
Due to the direct correlation between cell number and DNA content, cell numbers in day-28 
cultures of BMSCs in basal and osteogenic media were determined by measuring the 
cellular DNA concentration. In wild-type female mice, no differences in DNA concentration 
(and therefore cell number) were observed between day-28 BMSC cultures in basal and 
osteogenic media (Fig. 1B). In BMSC cultures of Bag-1 heterozygous female mice, DNA 
concentration of day-28 cultures in osteogenic medium was significantly higher than DNA 
concentration of day-28 cultures in basal medium (Fig. 1B). In both wild-type and Bag-1 
heterozygous male mice, DNA concentrations of day-28 BMSC cultures were significantly 
lower in osteogenic conditions compared to basal conditions (Supplementary Fig. 2B). In 
osteogenic medium, BMSCs of wild-type female mice demonstrated negligible rates of 
proliferation over the 28-day culture period, while BMSCs of Bag-1 heterozygous female 
mice exhibited significantly higher rates of proliferation over 28 days (Fig. 1C). BMSCs of 
wild-type and heterozygous male mice proliferated at significantly higher rates between days 
1 and 14 of culture, while proliferation of BMSCs in the two groups of male mice decreased 
significantly between days 14 and 28 of culture in osteogenic conditions (Supplementary Fig. 
2C). 
To examine the effect of haploinsufficiency of Bag-1 on the ability of BMSCs to differentiate 
into osteoblasts in response to BMP-2, 28-day cultures of BMSCs  of wild-type and Bag-1 
heterozygous mice were analysed for the expression of osteoblast-specific markers, namely 
Alkaline phosphatase, tissue non-specific isozyme (ALPL) and Osteocalcin. In wild-type 
female mice, specific activity of ALPL (Fig. 1D) and the concentration of osteocalcin (Fig. 1E) 
were significantly higher in day-28 BMSC cultures in osteogenic conditions compared to 
basal conditions. In Bag-1 heterozygous female mice, no significant differences in ALPL 
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specific activity (Fig. 1D) and osteocalcin concentration (Fig. 1E) were observed between 
day-28 BMSC cultures in basal and osteogenic media.  In contrast, in day-28 cultures of 
BMSCs of wild-type and Bag-1 heterozygous male mice, ALPL specific activity 
(Supplementary Fig. 2D) and osteocalcin concentration (Supplementary Fig. 2E) were 
significantly higher in osteogenic conditions compared to basal conditions.  In comparison to 
day-28 osteogenic cultures of BMSCs of Bag-1 heterozygous female mice, day-28 
osteogenic cultures of BMSCs of wild-type female mice exhibited higher number of colonies 
stained with Alizarin red (Supplementary Fig. 3).  
Overall, a very low incidence of apoptosis was observed in day-28 BMSC cultures. No 
differences in cell apoptosis were observed between day-28 basal and osteogenic cultures 
of BMSCs of wild-type and Bag-1 heterozygous female (Supplementary Fig. 4A) and male 
(Supplementary Fig. 4B) mice. 
Differential expression of skeletal development genes between osteogenic cultures of 
BMSCs of wild-type and Bag-1 heterozygous mice  
The mouse osteogenesis RT² Profiler™ PCR arrays were employed to examine the 
differences in the expression of 84 genes crucial for skeletal development between day-28 
osteogenic cultures of BMSCs of 14-week-old wild-type and Bag-1 heterozygous female 
mice. From the 84 genes constituting the array, 30 genes were differentially expressed 
between day-28 BMSC cultures of Bag-1+/+ and Bag-1+/- female mice in response to the 
osteogenic stimulus provided by BMP-2. Genes that were upregulated and downregulated in 
day-28 osteogenic cultures of Bag-1+/- BMSCs relative to day-28 osteogenic cultures of Bag-
1+/+ BMSCs, along with the values for fold up/downregulation and statistical significance 
have been listed (Supplementary Fig. 5A). A volcano plot, constructed by plotting the 
negative log of the p-value on the y-axis and log of the fold change between the two 
conditions on the x-axis, enabled rapid identification of the 30 differentially expressed genes 
(Supplementary Fig. 5B; red circles represent upregulated genes and green circles 
represent downregulated genes).  
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Nine genes were significantly upregulated in day-28 osteogenic cultures of Bag-1+/- BMSCs 
compared to day-28 osteogenic cultures of Bag-1+/+ BMSCs. The upregulated genes 
included Ahsg, Fgf-2, Fn-1, which have important roles in regulation of osteogenic 
differentiation, Col14a1, Col4a1, Gdf-10, Mmp-8, Tnfsf-11 and Vcam-1, which have 
important functions in collagen fibril organisation, remodelling of the extracellular matrix, 
osteoclastogenesis and cell adhesion (Fig. 2 and Supplementary Fig. 5A). Expression levels 
of 21 genes were downregulated in day-28 osteogenic cultures of Bag-1+/- BMSCs, in 
comparison to day-28 osteogenic cultures of Bag-1+/+ BMSCs. Key genes whose expression 
levels were downregulated included Bmp-2, Bmp-4, Bmp-7, Sp7, Pdgfa, Vegfa, which have 
important roles in regulation of osteogenic differentiation, Col1a1, Col1a2, Col5a1, Serpinh-1, 
which are important for collagen biosynthesis and whose products are vital constituents of 
the extracellular matrix, Spp1, Alpl, Sost, Bglap and Phex, which have regulatory roles in 
bone matrix mineralisation (Fig. 2).  
Effect of estrogen on BMP-2-directed osteogenic differentiation of BMSCs  
The expression levels of genes encoding the estrogen receptors, namely ER and ER, in 
day-28 cultures (in basal medium) of BMSCs of 14-week-old wild-type mice were compared 
to murine osteoblast-like MC3T3-E1 cells, which have been shown to express both receptor 
subtypes30. Mouse BMSCs were found to express genes encoding the two ER isoforms; in 
comparison to MC3T3-E1 cells, expression of ER was significantly lower in BMSCs, while 
expression of ER was significantly higher in BMSCs (Supplementary Fig. 6A). Osteogenic 
culture medium was supplemented with 17--estradiol (E2) in concentrations of 10pM, 
100pM, 10nM and 100nM to determine the optimal concentration of E2 capable of promoting 
BMP-2-directed osteogenic differentiation of BMSCs. Following culture for 28 days in basal, 
osteogenic and osteogenic media supplemented with different concentrations of E2, 
expression of Alpl was determined as an early marker of osteogenic differentiation of 
BMSCs. Expression of Alpl in wild-type BMSCs was significantly upregulated in response to 
BMP-2 in the osteogenic medium compared to basal culture conditions (Supplementary Fig. 
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6B). Moreover, in comparison to BMSCs cultured in osteogenic medium, statistically 
significant increase in the expression of Alpl was observed in BMSCs cultured for 28 days in 
osteogenic medium supplemented with 100nM E2 (Supplementary Fig. 6B). Furthermore, 
culture of BMSCs of 14-week-old wild-type and Bag-1 heterozygous female mice for 28 days 
in osteogenic medium supplemented with 100nM E2 resulted in significant increases in the 
expression of Bmpr2 (gene encoding BMP receptor Type II), compared to BMSC cultures in 
osteogenic medium (Supplementary Fig. 6C). 
Analysis of inhibition of the interaction between BAG-1 and HSC70 by Thioflavin-S on 
E2/ER-facilitated BMP-2-directed osteogenic differentiation of BMSCs  
Thioflavin-S, a small-molecule chemical inhibitor of the interaction between BAG-1 and heat 
shock proteins, was used to investigate the functional significance of BAG-1-mediated 
protein-protein interactions, specifically, BAG-1-regulated activation of ER by HSC70, in E2-
facilitated BMP-2-directed osteogenic differentiation of BMSCs. BMSCs of 14-week-old Bag-
1+/+ and Bag-1+/- female mice were cultured for 28 days in basal medium, osteogenic 
medium, osteogenic medium supplemented with 100nM E2 and osteogenic medium 
supplemented with 100nM E2 and 5µM Thioflavin-S. Day-28 BMSC cultures were harvested 
for the analyses of expression of osteogenic genes, namely Runx-2, Osterix, Alpl and 
Osteocalcin, estimation of ALPL specific activity and quantitation of DNA concentration.  
Compared to cultures in basal medium, day-28 cultures of BMSCs of Bag-1+/+ mice exhibited 
significantly increased expression of osteogenic genes (Fig. 3A) and significantly higher 
specific activity of ALPL (Fig. 3B) in osteogenic and E2-supplemented osteogenic media. 
Moreover, the osteogenic response was higher in day-28 cultures of BMSCs of Bag-1+/+ 
mice in osteogenic medium supplemented with E2, in comparison to day-28 cultures in 
osteogenic medium. BMSCs of Bag-1+/- female mice did not exhibit robust osteogenic 
differentiation in day-28 cultures in osteogenic medium compared to cultures in basal 
medium (Fig. 4A, B). This observation was in keeping with our previous findings, which 
demonstrated decreased osteogenic response to BMP-2 by BMSCs of Bag-1+/- female mice 
(Fig. 1D, E). Remarkably, expression of osteogenic genes (Fig. 4A) and specific activity of 
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ALPL (Fig. 4B) were significantly upregulated in day-28 BMSC cultures of Bag-1+/- female 
mice in osteogenic medium supplemented with E2, compared to day-28 cultures of Bag-1+/- 
BMSCs in osteogenic and basal media. In comparison to the robust osteogenic 
differentiation of Bag-1+/+ and Bag-1+/- BMSCs in day-28 cultures in E2-supplemented 
osteogenic medium, expression of osteogenic genes (Figs. 3A, 4A) and specific activity of 
ALPL (Figs. 3B, 4B) were significantly decreased in day-28 cultures of BMSCs of Bag-1+/+ 
and Bag-1+/- mice in E2-containing osteogenic medium supplemented with Thioflavin-S.  
Effect of inhibition of binding of BAG-1 to HSC70 by the BAG domain-derived short 
peptide on E2/ER-facilitated BMP-2-directed osteogenic differentiation of BMSCs  
BAG-1 binds to the ATPase domain of HSC70 via a very small region comprising of 8 amino 
acid residues in helix 2 of the C-terminal BAG domain. A short peptide, H2-Penetratin, 
containing the 8 amino acid binding core of helix 2 of the BAG domain coupled via a peptide 
bond to Penetratin, was synthesised to inhibit the binding of BAG-1 to HSC70. A mutant 
peptide, H2mutant-Penetratin, with alanine substitutions for arginine residues at positions 
205 and 206 that represented the ‘hot-spot’ on the interaction surface between BAG-1 and 
HSC70, was also synthesized as the control peptide. BMSCs of 14-week-old Bag-1+/+ and 
Bag-1+/- female mice were cultured for 28 days in basal medium, osteogenic medium 
supplemented with 100nM E2 and osteogenic medium supplemented with 100nM E2 in 
addition to either 10µM H2-Penetratin or 10µM H2mutant-Penetratin. Day-28 BMSC cultures 
were harvested for the analyses of expression of osteogenic genes, namely Runx-2, Osterix, 
Alpl and Osteocalcin, and estimation of ALPL specific activity, osteocalcin and DNA 
concentrations.  
In comparison to day-28 cultures in basal medium, significant increases in the expression of 
osteogenic genes (Figs. 5A, 6A), specific activity of ALPL (Figs. 5B, 6B) and osteocalcin 
concentration (Figs. 5C, 6C) were observed in day-28 cultures of BMSCs of Bag-1+/+ and 
Bag-1+/- mice in osteogenic medium supplemented with E2. Significant decreases in the 
expression of osteogenic genes (Figs. 5A, 6A), specific activity of ALPL (Figs. 5B, 6B) and 
osteocalcin concentration (Figs. 5C, 6C) were observed in day-28 cultures of BMSCs of 
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Bag-1+/+ and Bag-1+/- mice in osteogenic medium supplemented with E2 and H2-Penetratin, 
compared to day-28 cultures in osteogenic medium supplemented with E2. In contrast, 
H2mutant-Penetratin had no effect on E2/ER-facilitated BMP-2-directed osteogenic 
responses of BMSCs of Bag-1+/+ and Bag-1+/- mice. This was demonstrated by no 
differences in the expression of osteogenic genes (Figs. 5A, 6A), specific activity of ALPL 
(Figs. 5B, 6B) and osteocalcin concentration (Figs. 5C, 6C) between day-28 BMSC cultures 
in E2-supplemented osteogenic medium and osteogenic medium supplemented with E2 and 
H2mutant-Penetratin. Moreover, expression of osteogenic genes (Figs. 5A, 6A), specific 
activity of ALPL (Figs. 5B, 6B) and osteocalcin concentration (Figs. 5C, 6C) were 
significantly higher in day-28 BMSC cultures in osteogenic medium supplemented with E2 
and H2mutant-Penetratin, compared to day-28 cultures in osteogenic medium supplemented 
with E2 and H2-Penetratin.  
Effects of Thioflavin-S and the BAG-domain-derived short peptides on BMSC viability 
and proliferation 
No differences in cell number/DNA content between day-28 cultures of BMSCs (of both Bag-
1+/+ and Bag-1+/- mice) in E2-supplemented osteogenic medium and osteogenic medium 
supplemented with E2 and Thioflavin-S confirmed that Thioflavin-S was not toxic to the 
BMSCs (Fig. 7A). Similarly, BMSC viability and proliferation were unaffected by the short 
peptides, namely H2-Penetratin and H2mutant-Penetratin, as demonstrated by no 
differences in cell number/DNA concentrations between day-28 cultures of BMSCs (of both 
Bag-1+/+ and Bag-1+/- mice) in E2-supplemented osteogenic medium and osteogenic medium 
supplemented with E2 and the short peptides (Fig. 7B). 
 
Discussion 
The present study has highlighted the significance of BAG-1-regulated activation of ER by 
HSC70 in the modulation of E2-facilitated BMP-2-stimulated osteogenic differentiation of 
murine BMSCs. This work has therefore demonstrated for the first time the importance of 
BAG-1-mediated protein-protein interactions in the regulation of osteoblast development. 
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While both BAG-1 isoforms were expressed by murine BMSCs, expression of BAG-1S was 
observed to be higher than BAG-1L. This finding is in keeping with observations made by 
previous studies that BAG-1S is the major BAG-1 isoform in rodent cells11,15.  
To elucidate the causes of decreased BMP-2-directed osteogenic differentiation of BMSCs 
of Bag-1+/- female mice, differences in the expression of an array of genes crucial for skeletal 
development were analysed between osteogenic cultures of BMSCs of Bag-1+/- and Bag-1+/+ 
female mice. Increased expression of Ahsg (Fetuin), Fgf2 (Fibroblast growth factor-2) and 
Fn1 (Fibronectin) in osteogenic cultures of BMSCs of Bag-1+/- female mice contributed, in 
part, to the lower osteogenic response of the cells to BMP-2 and the increased rate of cell 
proliferation. Fetuin acts as an inhibitor of osteogenesis in rodent BMSC cultures due to its 
high affinity for binding to BMP2/4/6, thereby resulting in the inhibition of the osteogenic 
activity of BMPs31. Similarly, FGF-2 is shown to inhibit BMP-stimulated osteoblast 
differentiation and increased levels of FGF-2 are found to maintain osteoprogenitor cells in a 
proliferative state by delaying their subsequent differentiation, maturation and 
mineralisation32,33. Fibronectin, an extracellular matrix glycoprotein, is synthesised by 
osteoblasts and accumulates in the extracellular matrix during cell proliferation and early 
differentiation, while synthesis of fibronectin is dramatically reduced with cell maturation34. It 
is therefore possible that significant upregulation of Fn1 expression in osteogenic cultures of 
BMSCs of Bag-1+/- female mice, in comparison to osteogenic cultures of BMSCs of Bag-1+/+ 
female mice, reflects the highly proliferative/early differentiation state of the cells.  
The important roles of BMP-2, BMP-4 and BMP-7 in the induction of differentiation of 
osteoblast lineage cells have been widely recognised35-37. Downregulation of expression of 
the osteoinductive BMPs could have contributed to decreased osteogenic differentiation of 
Bag-1+/- BMSCs in comparison to Bag-1+/+ BMSCs. Additionally, expression levels of SP7 
(encoding the transcription factor Osterix), crucial for differentiation of preosteoblasts into 
functional osteoblasts38, Pdgfa, capable of regulating osteogenesis via autocrine and 
paracrine effects39 and Vegfa, responsible for promoting bone formation through induction of 
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neovascularisation or by directly stimulating osteoblast differentiation40, were significantly 
downregulated in osteogenic cultures of Bag-1+/- BMSCs.  
Furthermore, downregulation of expression of Col1a1, Col1a2, Col5a1, Serpinh1, Alpl, Spp1, 
Bglap and Phex in osteogenic cultures of BMSCs of Bag-1+/- female mice contributed to 
decreased synthesis of the bone matrix and its mineralisation. Type I collagen is the most 
abundant collagen in bone matrix, while Type V collagen is essential for the formation of 
normal Type I collagen fibrils due to the critical role of Type V collagen in early fibril initiation, 
determination of fibril structure and matrix organisation41. The collagen-specific molecular 
chaperone, Serpinh-1/HSP47, is located in the endoplasmic reticulum and plays an 
important role in collagen biosynthesis42. Matrix mineralisation is regulated by ALPL, an 
enzyme with a pivotal role in mineralisation43, Osteopontin (Spp1), which has key roles in 
mineral-binding and regulation of crystal growth44, Osteocalcin (Bglap), an osteoblast-
specific protein characterised by the presence of -carboxyglutamic acid (Gla) residues, 
which has a regulatory role in bone mineral maturation45,46 and Phex (Phosphate-regulating 
gene with homologies to endopeptidases on the X chromosome), encoding a protease 
responsible for the degradation and clearance of mineralisation-inhibiting ASARM (acidic 
serine and aspirate-rich motif) peptides that are derived from a group of extracellular matrix 
SIBLING (small integrin-binding ligand N-linked glycoprotein) proteins including MEPE 
(matrix extracellular phosphoglycoprotein) and osteopontin47.  
Interestingly, expression of Tnsf11 was upregulated almost 4-fold in BMSC cultures of Bag-
1+/- female mice compared to BMSC cultures of Bag-1+/+ female mice. The cytokine 
TNFSF11 (Tumor necrosis factor (ligand) superfamily, member 11 or RANKL: Receptor 
activator of nuclear factor kappa-B ligand), alongside macrophage colony stimulating factor 
(M-CSF), is essential for osteoclast formation48. Interaction of RANKL, expressed primarily 
on the surface of stromal cells and osteoblasts in the bone marrow, with RANK, expressed 
on the surface of blood-derived mononuclear osteoclast precursors, stimulates 
osteoclastogenesis49. Co-cultures of cells harvested from day-28 osteogenic cultures of 
BMSCs of Bag-1+/- female mice with blood-derived mononuclear cells will be established, as 
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part of the future work, to determine whether osteoclastogenesis of the monocytic osteoclast 
precursors is enhanced in response to increased expression of RANKL by the BMSCs.  
Bag-1 haploinsufficiency did not affect the osteogenic response of BMSCs of Bag-1 
heterozygous male mice to BMP-2; this highlighted the need to understand the role of 
interacting factors capable of modulating gender differences in BMP-2-directed osteogenic 
differentiation of BMSCs of Bag-1+/- mice. Estrogen, the primary female sex hormone, binds 
to estrogen receptors, ligand-activated enhancer proteins that are members of the NHR 
superfamily, and is functionally involved in the process of BMP-directed osteoblast 
differentiation of osteoprogenitor cells via upregulation of Bmpr2 expression and Smad 1/5/8 
phosphorylation28. The present study has demonstrated the expression of ERα and ERβ by 
primary murine BMSCs and significant upregulation of Bmpr2 expression in BMP-2-treated 
cultures of BMSCs supplemented with 100nM E2. Co-treatment of mouse BMSCs with BMP-
2 and E2 has been shown to enhance osteogenic lineage commitment of the multipotent cell 
population at the expense of adipogenic differentiation and the modulation of BMSC lineage 
shift towards the osteoblast phenotype by E2 occurred in an ER-specific manner, but without 
ER subtype specificity27. Thus, E2 increased the responsiveness of ER-expressing BMSCs 
of Bag-1+/+ and Bag-1+/- female mice to BMP-2 through upregulation of the expression of 
Bmpr2 and facilitated robust osteogenesis by enhancing the commitment of the BMSC 
population to differentiate into the osteoblast lineage.   
Thioflavin S functions as a small molecule chemical inhibitor of the interaction between BAG-
1 and HSC70, since the binding site for the compound lies within helix 2 of the BAG domain; 
alternatively, it is possible that Thioflavin S may bind elsewhere within BAG-1 and elicit a 
conformational change in the BAG domain, leading to the loss of multiple interaction 
partners, including HSC7029. Through its interaction with HSC70, BAG-1 can regulate the 
activation of NHRs, including ERs, and play an important role in the modulation of cellular 
responses to steroid hormones, such as E216,17. In the present study, Thioflavin S disrupted 
the binding between HSC70 and BAG-1 in BMSC cultures supplemented with BMP-2 and 
E2, resulting in the downregulation of E2-facilitated BMP-2-directed osteogenic 
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differentiation of BMSCs. Thioflavin S therefore served as a useful tool to elucidate the 
functional significance of BAG-1-regulated activation of ER by HSC70 in E2-facilitated BMP-
2-directed osteogenic differentiation of BMSCs. However, Thioflavin S/NSC71948 is a 
mixture of components arising from the methylation and sulfonation of primulin base, the 
selectivity profile of which is not fully characterised and thus, the likelihood of off-target 
effects cannot be ruled out50,51.  
Hence, to improve selectivity/specificity, a short peptide, H2-Penetratin, containing the 8 
amino acid binding core of helix 2, coupled via a peptide bond at its C-terminus to Penetratin, 
a fragment of the Antennaepaedia protein that enhances cellular uptake, was used to inhibit 
the binding between BAG-1 and HSC70 in BMSC cultures supplemented with BMP-2 and 
E2. The H2-Penetratin peptide has been demonstrated to bind the ATPase domain of 
HSC70 and exert its effects, such as growth inhibition, in human breast cancer cells by 
preventing the interaction between BAG-1 and HSC7020. Similarly, in our study, inhibition of 
binding of BAG-1 to HSC70 by H2-Penetratin resulted in significant downregulation of 
E2/ER-facilitated BMP-2-directed osteogenic responses of BMSCs of both Bag-1+/+ and Bag-
1+/- mice. The mutant peptide, with alanine substitutions for arginine residues at positions 
205 and 206 representing the ‘hot-spot’ on the interaction surface between BAG-1 and 
HSC70, was significantly less effective in downregulating the osteogenic responses of the 
BMSCs, thereby confirming the specificity of the H2-Penetratin peptide to disrupt the 
interaction between BAG-1 and HSC70 in BMSCs and cause downregulation of E2/ER-
facilitated BMP-2-directed osteogenic differentiation. 
Since no differences were observed in cell number/DNA content between day-28 cultures of 
BMSCs in osteogenic medium supplemented with E2 and osteogenic medium supplemented 
with E2, Thioflavin-S or the BAG domain-derived short peptides, decreased E2/ER-facilitated 
BMP-2-directed osteogenic responses of BMSCs in presence of Thioflavin S and the H2-
Penetratin peptide were not due to compromised cell viability. It is, however, important to 
note that, in addition to HSC70 binding, the BAG domain facilitates binding of BAG-1 to 
RAF-1 through helices 1 and 252. As the binding sites for HSC70 and RAF-1 overlap, which 
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can result in competitive binding, more specific mutations in the HSC70 binding region of the 
BAG domain will need to be created as part of the future work to gain valuable information 
regarding the significance of the independent role of the interaction of HSC70 with BAG-1 in 
the regulation of E2/ER-facilitated BMP-2-directed osteogenic differentiation of BMSCs. 
In summary, the present study has demonstrated that deletion of one functional Bag-1 allele 
decreased the potential of BMSCs of Bag-1+/- female mice to differentiate into osteoblasts in 
response to BMP-2. Although there are many mechanisms and targets of BAG-1 function, 
the ability of BAG-1 to regulate the activation of NHRs, critically, through its interaction with 
the HSC70/HSP70 chaperone proteins, has now been accepted as one of the key 
mechanisms of regulation of cellular functions by BAG-1. By highlighting the significance of 
the interaction between BAG-1 and HSC70 in the modulation of E2/ER-facilitated BMP-2-
directed osteogenic differentiation of BMSCs, our study has provided valuable insight into 
the role of BAG-1-mediated protein-protein interactions in the regulation of osteoblast 
development. Generation of conditional knockout mice in which the Bag-1 gene is deleted 
from osteoblast-lineage cells would aid comprehensive investigation of the role of Bag-1 in 
bone development. 
 
Materials and methods 
Chemicals and reagents were purchased from Invitrogen (Paisley, UK) and Sigma-Aldrich 
(Gillingham, UK) unless specified. 
Bag-1+/- mice 
The protocol for targeted inactivation of the mouse Bag-1 locus and the PCR strategy for 
genotyping Bag-1-/-, Bag-1+/- and Bag-1+/+ mice have been described previously12,14. The 
Bag-1+/- mice were provided by Prof. Stefan Wiese (Ruhr University Bochum, Germany) and 
bred in the Biomedical Research Facility, University of Southampton. The mice were housed 
in appropriate environments maintained at 21°C ± 2°C and 55% ± 10% humidity with 15-20 
room air changes per hour and 12-h/12-h light/dark cycles. The mice had free access to 
water and were fed ad libitum. All animal experimentation was performed under licence (Ref. 
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No. 70/6422) granted by the Home Office (UK) in accordance with the Animals (Scientific 
Procedures) Act 1986. 
Health and Safety risk assessments were performed for all experimental protocols and the 
protocols were approved by the Research Governance Office, University of Southampton. 
Cultures of mouse BMSCs  
Femora and tibiae were dissected from 14-week-old Bag-1+/- and Bag-1+/+ mice for isolation 
of BMSCs using an established protocol53. For each experiment, BMSCs were pooled from 
the femora and tibiae of 3-4 mice. The cells were plated in 6-well plates at a seeding density 
of 500,000 cells/cm2. After 6 days of culture in basal medium (phenol red-free α-MEM 
containing 1% penicillin/streptomycin, 10% charcoal stripped fetal calf serum/FCS and 50μM 
β-mercaptoethanol), non-adherent red blood cells were removed by washing the cultures 
using sterile PBS and tissue culture plastic-adherent stromal cells were cultured for further 
22 days in basal medium, osteogenic medium (basal medium supplemented with 100ng/ml 
rhBMP-2, 100µM ascorbate-2-phosphate), osteogenic medium supplemented with E2 (10pM, 
100pM, 10nM, 100nM), osteogenic medium supplemented with E2 (100nM) and Thioflavin-S 
(5µM), osteogenic medium supplemented with E2 (100nM) and H2-Penetratin/H2mutant-
Penetratin (10µM). As Thioflavin-S was reconstituted in dimethyl sulfoxide (DMSO) and the 
effective concentration of DMSO in the culture medium containing 5µM Thioflavin-S was 
0.05%, osteogenic medium containing 100nM E2 was supplemented with 0.05% DMSO in 
the experiments investigating the effect of Thioflavin-S. Cultures were harvested for 
detection of apoptosis, biochemical and molecular biology investigations.  
The peptides were ordered from ProteoGenix SAS (Schiltigheim, France) and reconstituted 
in ultrapure water. H2-Penetratin, CKLDRRVKATIERQIKIWFQNRRMKWKK, contained the 
8 amino acid binding core of helix 2 (sequence in italics), coupled via a peptide bond at its C-
terminus to Penetratin (sequence in bold), a cell permeable fragment of the Antennaepaedia 
protein that enhanced cellular uptake. H2mutant-Penetratin, 
AALDAAVKATIERQIKIWFQNRRMKWKK, was characterised by alanine (A) substitutions, 
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particularly for arginine (R) residues at positions 205 and 206 (underlined) that represented 
the ‘hot-spot’ on the interaction surface between BAG-1 and HSC70.  
Alizarin red staining 
Day-28 cultures of BMSCs were fixed using 4% paraformaldehyde. Following a PBS wash, 
Alizarin red solution (40mM, pH 4.1-4.3) was added to wells and the plates were incubated 
at room temperature for 20 minutes on the shaker.  Cultures were then washed number of 
times with fresh ultrapure water to remove the excess stain. Colonies stained with Alizarin 
red were observed using the Zeiss Axiovert 200 inverted fluorescence microscope (Carl 
Zeiss, Cambridge, UK) and imaged using a CCD camera with Axiovision imaging software. 
Detection of cell apoptosis 
Cell cultures were fixed using 4% paraformaldehyde and terminal deoxynucleotidyl 
transferase-mediated dUTP nick-end labeling (TUNEL) was performed using the Apoptosis 
Detection System (Promega, Southampton, UK) according to the manufacturer's instructions.  
Positive controls for detection of DNA fragmentation were prepared by treating BMSCs with 
DNase-1. Nuclei were labelled with Propidium iodide, staining was observed using the Zeiss 
Axiovert 200 inverted fluorescence microscope and imaged using a CCD camera with 
Axiovision imaging software. To quantify the results of apoptosis, Propidium iodide-stained 
nucleated cells and TUNEL-positive apoptotic cells were counted in five different fields of 
view, and the number of apoptotic cells was calculated as percentage of the total cell 
number. 
Biochemical investigations 
Cells harvested from the cultures were lysed in 0.05% Triton-X and the cell lysates were 
used for biochemical analyses, namely DNA quantification, estimation of ALPL specific 
activity and osteocalcin concentration.  
DNA quantification 
The fluorescent PicoGreen® double-stranded DNA quantification reagent was used for DNA 
quantification as described previously54. The fluorescence was measured using the FLX-800 
microplate fluorescence reader (excitation wavelength of 485nm, emission wavelength of 
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530nm) equipped with the BioTek KC4 KinetiCalc for Windows software (BioTek, Swindon, 
UK). The DNA content of the sample was quantified by comparison of the sample 
fluorescence to the fluorescence of a set of standards that were included in every sample 
run. 
Estimation of ALPL specific activity 
ALPL specific activity was measured as previously described54. In brief, the method involved 
the conversion of p-nitrophenyl phosphate by ALP to p-nitrophenol (pNP) and inorganic 
phosphate under alkaline conditions. The absorbance was measured at 410nm using ELX-
800 universal microplate reader equipped with the BioTek KC4 KinetiCalc for Windows 
software (BioTek, Swindon, UK). The concentration of pNP was quantified by comparison of 
the sample absorbance to the absorbance of a set of pNP standards that were included in 
every sample run. ALPL specific activity was calculated and expressed as nmol pNP/ng 
DNA/hr.  
Quantification of osteocalcin concentration 
Concentration of osteocalcin was measured using the mouse osteocalcin EIA kit (Bioquote 
Ltd., York, UK), a sandwich ELISA assay, following manufacturer’s instructions. The 
absorbance was measured at 450nm using the microplate reader and concentration of 
osteocalcin was quantified by comparison of the sample absorbance to the absorbance of a 
set of osteocalcin standards that were included in every sample run. The values were 
expressed as ng osteocalcin/ng DNA. 
Real-time quantitative PCR 
Total RNA was isolated using the RNeasy kit (Qiagen, Manchester, UK) following 
maunfacturer’s instructions. The RNA samples were treated with DNase-1 reagent and 
reverse-transcribed using the SuperScript® VILOTM kit. Real-time quantitative PCR assays 
were performed using the 7500 Real-Time PCR system (Applied Biosystems, Paisley, UK) 
for analysing the expression of, Runx-2 (F: 5’ CCACCACTCACTACCACACG 3’; R: 5’ CAC 
TCTGGCTTTGGGAAGAG 3’), Osterix (F: 5’ AGTTCACCTGCCTGCTCTGT 3’; R: 5’ CTC 
AAGTGGTCGCTTCTGGT 3’), Alpl (F: 5’ CTGACTGACCCTTCGCTCTC 3’; R: 5’ CCA 
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GCAAGAAGAAGCCTTTG 3’), Osteocalcin (F: 5’ CTGACCTCACAGATGCCAAG 3’; R: 5’ 
ACCTTATTGCCCTCCTGCTT 3’), ER (F: 5’ CCTTCTAGACCCTTCAGTGAAGCC 3’; R: 5’ 
CGAGACCAATCATCAGAATCTCC 3’), ER (F: 5’ CAGTAACAAGGGCATGGAAC 3’; R: 5’ 
GTACATGTCCCACTTCTGAC 3’) and Bmpr2 (F: 5’ GAAACGATAATCATTGCTTTGGC 3’; 
R: 5’ CCCTGTTTCCGGTCTCCTGT 3’). The expression levels of the genes of interest were 
normalised to the expression level of the housekeeping gene/endogenous control, β-actin (F: 
5’ TTGCTGACAGGATGCAGAAG 3’; R: 5’ GTACTTGCGCTCAGGAGGAG 3’). Since the 
SYBR Green mastermix was used, primer sequences for the genes were validated by 
dissociation curve/melt curve analysis to rule out the formation of secondary structures, such 
as primer dimers and hairpin loops. The relative transcript levels of genes of interest were 
analysed using the comparative CT method (ΔΔCT method). For valid ΔΔCT calculation, the 
efficiencies of the primers used for amplification of the target sequences in the genes of 
interest were confirmed to be approximately equal to the efficiency of the primers used for 
amplification of the target sequence in the housekeeping gene. Fold changes (2-CT) in 
relative transcript levels were normalised to the endogenous reference (β-Actin) and plotted 
as bar graphs. The range of gene expression was indicated by 2-(CT 
+ SD) and 2-(CT 
- SD), 
where SD: standard deviation of the CT/CT value. Statistical analyses were performed at 
the level of ΔCT in order to exclude potential bias due to averaging of data transformed 
through the 2- ΔΔCT equation. 
PCR array 
The mouse osteogenesis PCR array (RT2Profiler PCR Array – Qiagen, Manchester, UK) 
was used according to the manufacturer’s protocol to analyse the expression of 84 genes 
related to skeletal development. The PCR arrays were performed in triplicate using the 7500 
Real-Time PCR system and results were analysed using RT2Profiler PCR array data 
analysis version 3.5. Five housekeeping genes, namely β-Actin, β-2-Microglobulin, 
Glyceraldehyde-3-phosphate dehydrogenase, β-Glucoronidase, α-Heat shock protein 90, 
were included in the array for normalisation of data. The threshold for the fold–change in 
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gene expression was set at 2 and the significance of the difference in gene expression was 
calculated with the P-value set at 0.05.  
Immunoblotting 
Cell lysates were prepared using the radioimmunoprecipitation assay (RIPA) buffer and 
protein concentrations in the lysates were determined using the Pierce™ BCA protein assay 
kit (ThermoFisher Scientific, Loughborough, UK). The samples (12µg protein per well in 15µl 
loading volume) were resolved in 10% SDS bisacrylamide gels and electroblotted onto 
nitrocellulose membranes. The membranes were probed with rabbit anti-BAG-1/C-16 (Santa 
Cruz Biotechnology, Heidelberg, Germany) and rabbit anti--actin primary antibodies, used 
at 1:200 and 1:3000 dilutions, respectively, followed by the goat anti-rabbit IgG–Peroxidase 
conjugate secondary antibody (1:5000 dilution). Immobilon Western Chemiluminescent HRP 
Substrate (Merck Millipore UK Ltd, Watford, UK) was used for signal detection. For digital 
acquisition of the chemiluminescent signals, blots were imaged using the VersaDoc Imaging 
System (Bio-Rad Laboratories Ltd., Hemel Hempstead, UK) and data were analysed using 
Quantity One® 1-D analysis software. Expression of the BAG-1L and BAG-1S proteins were 
normalised to β-actin. 
Statistical analyses  
Statistical analyses were performed using the GraphPad Prism software (GraphPad 
Software Inc., San Diego, USA). The data is representative of a minimum of three 
independent experimental repeats and the results are presented as mean ± SD. Depending 
upon the experimental design, differences between the groups were analysed using paired t-
test, unpaired t-test (two-tailed P value) and one-way analysis of variance (ANOVA) with 
Tukey’s post-hoc test. Results were deemed significant if the probability of occurrence by 
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Figure 1. Proliferation and BMP-2-stimulated osteogenic differentiation of BMSCs of 14-
week-old Bag-1+/+ and Bag-1+/- female mice. (A) Representative immunoblots demonstrating 
bands for BAG-1L, BAG-1S and -Actin in day-28 cultures of BMSCs of Bag-1+/- and  
Bag-1+/+ female mice in basal medium. Densitometric quantification of the bands was 
performed to measure the expression of the BAG-1L and BAG-1S proteins, data was 
normalised to β-Actin and plotted in the form of bar graphs. (B) DNA concentrations of day-
28 cultures of BMSCs of Bag-1+/+ and Bag-1+/- female mice in basal and osteogenic media. 
(C) Cell proliferation profiles over the course of 28-day osteogenic cultures of BMSCs of 
Bag-1+/+ and Bag-1+/- female mice. For statistical analyses, DNA concentrations were 
compared between days 1 and 14 of culture, and days 14 and 28 of culture. (D) ALPL 
specific activity and (E) osteocalcin concentration were measured in day-28 cultures of 
BMSCs of Bag-1+/+ and Bag-1+/- female mice in basal and osteogenic media. Results 
presented as mean ± SD; n = 3 cultures per group; ***P<0.001, **P<0.01, *P<0.05. 
 
Figure 2. Fold changes in the expression of candidate genes from the mouse osteogenesis 
RT² Profiler™ PCR array in day-28 osteogenic cultures of BMSCs of 14-week-old Bag-1+/- 
female mice relative to day-28 osteogenic cultures of BMSCs of age-matched Bag-1+/+ 
female mice. Fold changes in the expression of genes crucial for osteogenic differentiation, 
bone matrix synthesis and mineralization were plotted in the form of bar graphs. The PCR 
arrays were performed in triplicate and the results were analysed using RT2Profiler PCR 
array data analysis version 3.5.  The threshold for the fold–change in gene expression was 
set at 2 and the significance of the difference in gene expression was calculated with the P-
value set at 0.05. 
 
Figure 3. Effect of Thioflavin-S (ThS), a small-molecule chemical inhibitor of the interaction 
between BAG-1 and HSC70, on E2/ER-facilitated BMP-2-directed osteogenic differentiation 
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of BMSCs of 14-week-old Bag-1+/+ female mice. (A) Expression levels of osteogenic genes, 
namely Runx-2, Osterix, Alpl and Osteocalcin, were measured in day-28 cultures of BMSCs 
in basal, osteogenic, osteogenic + E2, osteogenic + E2 + Thioflavin-S media. Fold changes 
(2-CT) in relative mRNA transcript levels were normalised to the endogenous reference (β-
Actin) and plotted as bar graphs. The range of gene expression was indicated by 2-(CT 
+ SD) 
and 2-(CT 
- SD), where SD: standard deviation of the CT/CT value. (B) Specific activity of 
ALPL (presented as mean  SD) was measured in day-28 cultures of BMSCs in basal, 
osteogenic, osteogenic + E2, osteogenic + E2 + Thioflavin-S media; n = 3 cultures per group; 
*** P<0.001.  
 
Figure 4. Effect of Thioflavin-S (ThS), a small-molecule chemical inhibitor of the interaction 
between BAG-1 and HSC70, on E2/ER-facilitated BMP-2-directed osteogenic differentiation 
of BMSCs of 14-week-old Bag-1+/- female mice. (A) Expression levels of osteogenic genes, 
namely Runx-2, Osterix, Alpl and Osteocalcin, were measured in day-28 cultures of BMSCs 
in basal, osteogenic, osteogenic + E2, osteogenic + E2 + Thioflavin-S media. Fold changes 
(2-CT) in relative mRNA transcript levels were normalised to the endogenous reference (β-
Actin) and plotted as bar graphs. The range of gene expression was indicated by 2-(CT 
+ SD) 
and 2-(CT 
- SD), where SD: standard deviation of the CT/CT value. (B) Specific activity of 
ALPL (presented as mean  SD) was measured in day-28 cultures of BMSCs in basal, 
osteogenic, osteogenic + E2, osteogenic + E2 + Thioflavin-S media; n = 3 cultures per group; 
*** P<0.001. 
 
Figure 5. Effect of inhibition of BAG-1 binding to HSC70 by the C-terminal BAG domain-
derived short peptide (H2-Penetratin) on E2/ER-facilitated BMP-2-directed osteogenic 
differentiation of BMSCs of 14-week-old Bag-1+/+ female mice. (A) Expression levels of 
osteogenic genes, namely Runx-2, Osterix, Alpl and Osteocalcin, were measured in day-28 
cultures of BMSCs in basal, osteogenic + E2, osteogenic + E2 + H2-Penetratin, osteogenic 
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+ E2 + H2mutant-Penetratin media. Fold changes (2-CT) in relative mRNA transcript levels 
were normalised to the endogenous reference (β-Actin) and plotted as bar graphs. The 
range of gene expression was indicated by 2-(CT 
+ SD) and 2-(CT 
- SD), where SD: standard 
deviation of the CT/CT value. (B) Specific activity of ALPL and (C) concentration of 
osteocalcin were determined in day-28 cultures of BMSCs in basal, osteogenic + E2, 
osteogenic + E2 + H2-Penetratin, osteogenic + E2 + H2mutant-Penetratin media. Results for 
ALPL specific activity and osteocalcin concentration presented as mean  SD; n = 3 cultures 
per group; *** P<0.001.  
 
Figure 6.  Effect of inhibition of BAG-1 binding to HSC70 by the C-terminal BAG domain-
derived short peptide (H2-Penetratin) on E2/ER-facilitated BMP-2-directed osteogenic 
differentiation of BMSCs of 14-week-old Bag-1+/- female mice. (A) Expression levels of 
osteogenic genes, namely Runx-2, Osterix, Alpl and Osteocalcin, were measured in day-28 
cultures of BMSCs in basal, osteogenic + E2, osteogenic + E2 + H2-Penetratin, osteogenic 
+ E2 + H2mutant-Penetratin media. Fold changes (2-CT) in relative mRNA transcript levels 
were normalised to the endogenous reference (β-Actin) and plotted as bar graphs. The 
range of gene expression was indicated by 2-(CT 
+ SD) and 2-(CT 
- SD), where SD: standard 
deviation of the CT/CT value. (B) Specific activity of ALPL and (C) concentration of 
osteocalcin were determined in day-28 cultures of BMSCs in basal, osteogenic + E2, 
osteogenic + E2 + H2-Penetratin, osteogenic + E2 + H2mutant-Penetratin media. Results for 
ALPL specific activity and osteocalcin concentration presented as mean  SD; n = 3 cultures 
per group; *** P<0.001.   
 
Figure 7. DNA concentrations of day-28 cultures of BMSCs of 14-week-old Bag-1+/+ and 
Bag-1+/- female mice. The DNA concentrations of day-28 cultures of BMSCs in osteogenic 
media supplemented with E2 were not altered by the addition of Thioflavin-S (A) and C-
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terminal BAG domain-derived short peptides (B). Results presented as mean  SD; n = 3 
cultures per group.  
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